Atlas Molecular Pharma
PrivateLast Round
Grant
Jun 17, 2025
Total Funding Raised
$2.5M
Company Overview
Atlas Molecular Pharma is a biotechnology company that discovers and develops first-in-class, innovative therapeutics for the treatment of rare and ultra-rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlas Molecular Pharma Comparables
Compare Atlas Molecular Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Protego Biopharma | 82% | |
| Pluvia Biotech | 81% | |
| Stablix | 78% | |
Atlas Molecular Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2025 | ||||
| VC Round | Feb 2, 2022 | ||||
| Seed | Sep 13, 2016 |
Key People
Founding team and executive leadership
Atlas Molecular Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inveready | VC Round |
| Center for Technological Development and Innovation | VC Round |
| CRB Health Tech | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 34% MoM, reaching 1.4K.
- Feb 23, 2026
Grew 57% QoQ from 7 to 11 employees.
Atlas Molecular Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atlas Molecular Pharma's valuation, stock price, and market status.